Fasting Glucose Changes in Adolescents with Polycystic Ovary Syndrome Compared with Obese Controls: A Retrospective Cohort Study

被引:5
作者
Javed, Asma [1 ]
Lteif, Aida N. [1 ]
Kumar, Seema [1 ]
Simmons, Patricia S. [2 ]
Chang, Alice Y. [3 ]
机构
[1] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Endocrinol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat & Adolescent Gynecol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Internal Med Diabet Metab & Nutr, Div Endocrinol, Rochester, MN 55905 USA
关键词
Hypertension; Impaired fasting glucose; Polycystic ovary syndrome; ORAL-CONTRACEPTIVES; INSULIN-RESISTANCE; RISK-FACTORS; METABOLIC SYNDROME; ANDROGEN EXCESS; WOMEN; PREVALENCE; TOLERANCE; CRITERIA; THERAPY;
D O I
10.1016/j.jpag.2015.01.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Study Objective: To compare changes in fasting glucose among adolescents with polycystic ovary syndrome (PCOS) with those in obese adolescents without PCOS. Design, Setting, and Participants: Retrospective cohort study of 310 adolescents with PCOS and 250 obese adolescents (age range 13 to 18 years) seen at Mayo Clinic, Rochester, MN, from 1996 to 2012. Methods: Included for analysis were 98 adolescents with PCOS and 150 obese adolescents who had 2 or more fasting glucose measurements separated by at least 6 months. Adolescents with impaired fasting glucose (IFG) or diabetes were excluded. Multivariate models were used to assess predictors of change in fasting glucose. Results: At diagnosis, adolescents with PCOS had lower body mass index (BMI) (kg/m(2)) and older age than obese adolescents (P < .001). Adolescents with PCOS had shorter follow-up (P = .02). Baseline fasting glucose was not different between groups. Mean change in fasting glucose was 2.4 +/- 9.4 mg/dL per year for PCOS and 2.2 +/- 6.2 mg/dL per year for obese adolescents (P = .83). Significant predictors for change in fasting glucose were BMI and fasting glucose at diagnosis (P < .01). Within the PCOS cohort, BMI was a significant predictor for development of IFG (P = .003). Prevalence of hypertension increased in the PCOS cohort from baseline to follow-up (P = .02). PCOS and BMI were significantly associated with development of HTN in the entire cohort. Conclusion: Adolescent girls with PCOS do not show a significant change in fasting glucose or an increased risk for the development of IFG compared with obese adolescents. BMI, not PCOS status, was the strongest predictor for changes in fasting glucose and development of IFG over time.
引用
收藏
页码:451 / 456
页数:6
相关论文
共 41 条
[1]  
Allen HF, 2005, J PEDIATR ENDOCR MET, V18, P761
[2]   Derivation and Validation of Automated Electronic Search Strategies to Identify Pertinent Risk Factors for Postoperative Acute Lung Injury [J].
Alsara, Anas ;
Warner, David O. ;
Li, Guangxi ;
Herasevich, Vitaly ;
Gajic, Ognjen ;
Kor, Daryl J. .
MAYO CLINIC PROCEEDINGS, 2011, 86 (05) :382-388
[3]   EARLY MENARCHE, A RISK FACTOR FOR BREAST-CANCER, INDICATES EARLY ONSET OF OVULATORY CYCLES [J].
APTER, D ;
VIHKO, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (01) :82-86
[4]   Glucose intolerance in obese adolescents with polycystic ovary syndrome:: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease [J].
Arslanian, SA ;
Lewy, VD ;
Danadian, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :66-71
[5]   Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation [J].
Asagami, Tomoko ;
Holmes, Tyson H. ;
Reaven, Gerald .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (10) :1355-1360
[6]   The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[7]   Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selma F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4237-4245
[8]   The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[9]   Impact of body mass index on blood pressure levels in patients with polycystic ovary syndrome [J].
Barcellos, Cristiano R. G. ;
Rocha, Michelle P. ;
Hayashida, Sylvia A. Y. ;
Mion Junior, Decio ;
Lage, Silvia G. ;
Marcondes, Jose A. M. .
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (07) :1104-1109
[10]   Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel [J].
Cagnacci, A ;
Paoletti, AM ;
Renzi, A ;
Orrù, M ;
Pilloni, M ;
Melis, GB ;
Volpe, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3621-3625